Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
E-Therapeutics PLC (GB:ETX)
LSE:ETX
E Therapeutics (ETX) Share Price & Analysis
5 Followers
ETX Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range8.00p - 24.00p
Previous Close10.25p
Volume1.24M
Average Volume (3M)586.93K
Market Cap
£59.89M
Enterprise Value28.50M
Total Cash (Recent Filing)£31.69M
Total Debt (Recent Filing)£295.00K
Price to Earnings (P/E)-6.4
Beta-0.17
Next Earnings
May 02, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding583,844,162
10 Day Avg. Volume763,750
30 Day Avg. Volume586,934
Standard Deviation0.23
R-Squared0.03
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)2.15
Price to Sales (P/S)62438.89
Price to Cash Flow (P/CF)-4.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
14.47% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
85.53% Public Companies and
Individual Investors
ETX FAQ
What was E-Therapeutics PLC’s price range in the past 12 months?
E-Therapeutics PLC lowest share price was 8.00p and its highest was 24.00p in the past 12 months.
What is E-Therapeutics PLC’s market cap?
Currently, no data Available
When is E-Therapeutics PLC’s upcoming earnings report date?
E-Therapeutics PLC’s upcoming earnings report date is May 02, 2024 which is in 8 days.
How were E-Therapeutics PLC’s earnings last quarter?
E-Therapeutics PLC released its earnings results on Oct 26, 2023. The company reported -0.01p earnings per share for the quarter, missing the consensus estimate of N/A by -0.01p.
Is E-Therapeutics PLC overvalued?
According to Wall Street analysts E-Therapeutics PLC’s price is currently Overvalued.
Does E-Therapeutics PLC pay dividends?
E-Therapeutics PLC does not currently pay dividends.
What is E-Therapeutics PLC’s EPS estimate?
E-Therapeutics PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does E-Therapeutics PLC have?
E-Therapeutics PLC has 584,335,500 shares outstanding.
What happened to E-Therapeutics PLC’s price movement after its last earnings report?
E-Therapeutics PLC reported an EPS of -0.01p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.239%.
Which hedge fund is a major shareholder of E-Therapeutics PLC?
Currently, no hedge funds are holding shares in GB:ETX
---
E Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.64%
12-Months-Change
Fundamentals
Return on Equity
-38.75%
Trailing 12-Months
Asset Growth
12.76%
Trailing 12-Months
Company Description
E-Therapeutics PLC
e-Therapeutics PLC is a drug discovery company. The company's discovery platform is based on the network of pharmacology and chemical biology. The company operates in a single business segment of drug discovery and development. By applying its computational platform to the discovery of new drug candidates, it can secure robust intellectual property rights. It applies specialized biological expertise and sophisticated computational techniques to model and analyze biological networks and hence identify key proteins that are relevant to a disease.
---
Technical Analysis
---